Among recipients of subcutaneous implantable cardioverter defibrillators, the omission of defibrillation testing (DT) was not associated with significant differences in mortality, or in the rates of ...
BOSTON — An investigative small-diameter defibrillation lead for implantable cardioverter-defibrillators has exceeded its safety and efficacy expectations in a pivotal clinical trial. The LEADR trial ...
San Clemente-based cardiac device company AtaCor Medical announced a collaboration with Abbott Laboratories to develop a next ...
Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator platform may benefit patients with HF not eligible for cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results